Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

423
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
423
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

175
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
175
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

251
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
251

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage-Induced Senescent Cancer-Associated Fibroblasts Promote SASP-Mediated Chemoresistance in Colorectal Cancer.

Cancer research·2026
Same author

MAGED4 promotes hepatocellular carcinoma progression via activation of JAK2/STAT3 pathway by stabilizing TRIM21.

Cell cycle (Georgetown, Tex.)·2026
Same author

Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy.

Signal transduction and targeted therapy·2026
Same author

Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy.

Nature cancer·2026
Same author

The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy.

Cancer communications (London, England)·2026
Same author

Single-cell multi-omics reveals DUSP9 as a key regulator of cancer stemness and a potential therapeutic target in hepatocellular carcinoma.

Journal of translational medicine·2026

Related Experiment Video

Updated: Aug 24, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

279

Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for

Libo Wang1,2,3, Zaoqu Liu4, Ruopeng Liang1,2,3

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Elife
|October 25, 2022
PubMed
Summary

This study developed an artificial intelligence-derived prognostic signature (AIDPS) to predict pancreatic cancer (PACA) outcomes. The AIDPS accurately identifies patient prognosis and guides personalized treatment strategies for this aggressive cancer.

Keywords:
biomarkercancer biologycomputational biologyhumanimmunotherapymachine learningmulti‐omicpancreatic cancersystems biology

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.8K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.9K

Related Experiment Videos

Last Updated: Aug 24, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

279
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.8K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.9K

Area of Science:

  • Oncology
  • Bioinformatics
  • Artificial Intelligence in Medicine

Background:

  • Pancreatic cancer (PACA) remains highly aggressive with stagnant survival rates over the past decade.
  • Current TNM staging lacks precision in identifying patients responsive to specific treatments.
  • There is a critical need for novel biomarkers to enable precision medicine in PACA.

Purpose of the Study:

  • To develop and validate an artificial intelligence-derived prognostic signature (AIDPS) for predicting pancreatic cancer patient outcomes.
  • To assess the predictive capability of AIDPS compared to existing signatures and clinicopathological features.
  • To explore the clinical implications of AIDPS in guiding individualized treatment strategies for PACA.

Main Methods:

  • Screening of 32 consensus prognostic genes from expression data of 1280 patients across 10 multicenter cohorts.
  • Utilizing ten machine-learning algorithms in 76 combinations to construct the optimal AIDPS based on C-index.
  • Validation of AIDPS using training, nine testing, Meta-Cohort, and three external validation cohorts (290 patients).

Main Results:

  • The AIDPS demonstrated consistent and accurate prognostic prediction across all validation cohorts for pancreatic cancer.
  • AIDPS exhibited superior predictive performance when integrated with clinicopathological features and compared against 86 published signatures.
  • The nine-gene AIDPS also showed efficacy in stratifying prognosis for other digestive system tumors.
  • Low AIDPS scores correlated with poor prognosis, higher genomic alterations, increased immune cell infiltration, and greater sensitivity to immunotherapy.
  • High AIDPS scores indicated prolonged survival, with panobinostat identified as a potential therapeutic agent.

Conclusions:

  • The developed AIDPS serves as a robust tool for accurate prognosis prediction in pancreatic cancer.
  • AIDPS has significant clinical implications for guiding individualized treatment and management strategies.
  • The signature's ability to stratify patients based on prognosis, genomic alterations, and immune profiles supports its role in precision oncology.